📰 Prosper Study News
Prosper Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prosper Study. Real-time updates on events, politics, business and more.
June 5, 2023
Expert panelists highlight aspects of a final patient scenario, discussing adjuvant treatment strategies in the setting of renal cell carcinoma at intermediate-high risk for recurrence.
April 5, 2023
A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.
April 5, 2023
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
March 30, 2023
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.